Impact Biomedical (IBO) Income from Continuing Operations (2022 - 2026)
Impact Biomedical's Income from Continuing Operations was -$1,000 in Q3 2026, compared with $5,000 a year earlier.
Powered by 
Analysis
Impact Biomedical (IBO) Income from Continuing Operations (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Impact Biomedical's Income from Continuing Operations was $7,000 through Sep 30, 2026, down 85.1% year-over-year; for FY2025, it was $32,000, down 48.4% from FY2024.
- Income from Continuing Operations has now declined for three consecutive years, with a three-year compound annual growth rate of -46.1% (FY2022 to FY2025).
- In earlier years, Income from Continuing Operations was $62,000 in FY2024 (-12.7%), $71,000 in FY2023 (-65.2%) and $204,000 in FY2022.
- Quarterly Income from Continuing Operations has moved between -$3.37 million (Q4 2022) and $192,000 (Q1 2023) over five years.
- Per Business Quant data, IBO's Income from Continuing Operations in the three quarters before Q3 2026 was $1,000 (Q2 2026), -$3,000 (Q1 2026) and $10,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | -1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,000.00 |
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | -884,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Dec 31, 2023 | 26,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Jun 30, 2023 | -1.12 Mn |
| Mar 31, 2023 | 192,000.00 |
| Dec 31, 2022 | -3.37 Mn |
| Sep 30, 2022 | -2.24 Mn |
| Jun 30, 2022 | -799,000.00 |
API Access
Impact Biomedical Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();